Scientists have identified 22 pesticides consistently linked to prostate cancer in the United States, and four of them are also linked to prostate cancer mortality. The results were published by Wiley online at CANCERpeer-reviewed journal of the American Cancer Society. To assess at the county level the association of 295 pesticides with prostate cancer in […]
A recent study reveals how C210, a curcumin derivative, selectively reactivates the Epstein-Barr virus to kill cancer cells without the risk of infection, paving the way for safer, targeted cancer therapies. Study: Curcumin derivative C210 induces the Epstein-Barr virus lytic cycle and inhibits virion production by interfering with Hsp90 function. Photo credit: Stephanie Frey / […]
A novel study shows that specialized ribosomes, driven by cytokine signals, lend a hand cancers evade the immune system, offering a breakthrough route to enhancing cancer immunotherapy. Test: P-stalk ribosomes act as master regulators of cytokine-mediated processes. Image source: ALIOUI MA / Shutterstock In a recent study published in the journal Cellresearchers have performed extensive […]
A recent case report was published in Onconscience (Volume 11) dated October 8, 2024, titled “Complete and Long-Term Response to Immunotherapy in Stage IV Non-Petite Cell Lung Cancer with Brain Metastases.” As highlighted in the summary of this report, approximately 20% of lung cancer patients have brain metastases at the time of diagnosis, which is […]
When researchers at the University of Michigan’s Rogel Cancer Center first identified a fresh subtype of aggressive prostate cancer, they knew they had to understand how this genetic change causes cancer and how to target its treatment. In two fresh articles, both published in Medicine Cell Reportsare doing both, describing the mechanisms of how changes […]
A up-to-date report from the American Cancer Society shows a decline in the breast cancer death rate in the United States. While this is a relief, the report also warns that breast cancer rates are rising among younger women and disparities persist between different racial groups. According to reportbetween 2012 and 2021, the incidence of […]
Research presented at ESMO 2024 reveals modern groups of women with early stage endometrial and cervical cancer who could benefit significantly from adding immunotherapy to current standard treatments. A first-in-human study has shown “promising” anti-tumour activity of a novel antibody-drug conjugate (ADC) targeting the protein claudin 6 in heavily pre-treated patients with ovarian and endometrial […]
The antibody-drug conjugate (ADC) puxitatug samrotecan (AZD8205) demonstrated an adequate safety profile consistent with similar ADCs and initial efficacy in heavily pretreated patients with advanced or metastatic solid tumors, according to interim data shared today at the European Society for Medical Oncology (ESMO) 2024 Congress by investigators at The University of Texas MD Anderson Cancer […]
In a recent study published in Nature Machine Intelligence introduces an advanced artificial intelligence (AI) model capable of creating virtual colors of tumor tissue. The study, co-led by scientists from the Universities of Lausanne and Bern, is an crucial step forward in improving pathological analysis and cancer diagnostics. By combining inventive computational techniques, a team […]
In a recent prospective observational cohort study published in eMedicineClinicalResearchers evaluated a modified total neoadjuvant treatment (TNT) regimen in patients with high-risk locally advanced rectal cancer (LARC) in Sweden. The modified TNT regimen was found to achieve similar complete response (CR) rates and lower neurotoxicity compared with the RAPIDO study, despite treating older patients with […]
